- bitBiome and Kyoritsu Seiyaku have entered a joint development agreement focused on animal health and nutrition.
- The collaboration will combine microbial biotechnology with veterinary expertise to develop new biological solutions.
- bitBiome will lead product development and manufacturing while both companies pursue global commercialization.
- The partnership aims to create sustainable biotechnology-based solutions for livestock and companion animals.
- bitBiome’s microbial discovery platform contains more than 2.5 billion genetic sequences used for enzyme and strain engineering.
Combining Biotechnology and Veterinary Expertise
The collaboration brings together bitBiome’s microbial discovery and engineering capabilities with Kyoritsu Seiyaku’s experience in veterinary medicine.
bitBiome has developed a technology platform that integrates a large microbial sequence database with enzyme discovery, strain engineering, and scalable biomanufacturing processes. The company says the platform enables the discovery and development of new biological solutions that can be produced efficiently.
By combining these capabilities with Kyoritsu Seiyaku’s experience in veterinary pharmaceuticals, the companies aim to deliver new biotechnology-based solutions for both livestock and companion animals.
bitBiome CEO Yuji Suzuki said bio-based products will play an increasingly important role in building more sustainable industries.
He noted that the collaboration is intended to improve animal health management through innovative technologies and products.
Focus on Sustainable Animal Health Solutions
Kyoritsu Seiyaku has supported animal health for decades through the development and distribution of veterinary pharmaceuticals for pets and livestock.
Through the collaboration, the company plans to translate emerging biotechnology innovations into practical veterinary solutions.
The partners say the initiative also aligns with broader efforts to address global challenges such as sustainability and the need for more efficient biological production systems.
About the Companies
Kyoritsu Seiyaku Corporation, founded in 1955, develops, manufactures, and distributes veterinary pharmaceuticals for dogs, cats, and livestock in Japan and international markets.
bitBiome is a biotechnology company focused on unlocking microbial diversity to develop bio-based products. Its technology platform includes the proprietary bit-MAP single-cell microbial genome analysis system and the bit-GEM microbial database, which contains more than 2.5 billion genetic sequences.
The company uses bioinformatics, machine learning, and artificial intelligence tools to identify enzymes and engineer biological pathways for new bio-manufactured products.
Information sourced from the company’s press release.
